NSE: CIPLA | BSE: 500087

Mid-range Performer

Download real time

1508.65 16.05 (1.08%)

1.6M NSE+BSE Volume

NSE 18 Mar, 2025 3:31 PM (IST)

121,840.8

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Cipla Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CIPLA, BSE:500087 Cipla Ltd.

Cipla Ltd.

30 Oct 2024

1508.65

1.08%

Cipla (SELL): No meaningful incremental triggers until Goa plant clearance

Sell: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Earnings in line with our estimates on all fronts. However, US sales was down and 5% lower than our estimates in rupee terms

Number of FII/FPI investors decreased from 1132 to 1077 in Dec 2024 qtr

Cipla Ltd.

29 Oct 2024

1508.65

1.08%

Meaningful new launches to drive growth

Buy: Cipla Ltd.

Target

Sharekhan

Cipla’s revenue reached Rs. 7,051 crore, reflecting a 7% y-o-y increase and a 6% q-o-q rise, meeting our expectations.

Number of FII/FPI investors decreased from 1132 to 1077 in Dec 2024 qtr

Cipla Ltd.

02 Aug 2024

1508.65

1.08%

Improving visibility in North America’s sales to aid in growth

Accumulate: Cipla Ltd.

Recommendation

KRChoksey

The Q1FY25 performance was slightly below estimates with Cipla’s sales/Gross Profits/EBITDA and PAT for Q1FY25 deviating by -3.2%/-1.6%/-3.2%/-2.3% from our estimates. It was due to weaker than expected performance in SAGA and API partially offset by marginally higher than estimated, US (+3.2%) and Emerging Markets (+3.8%).

Cipla Ltd. has an average target of 1707.30 from 11 brokers.

Cipla Ltd.

29 Jul 2024

1508.65

1.08%

Cipla Limited

Buy: Cipla Ltd.

Target

ICICI Direct

Cipla Ltd. has an average target of 1707.30 from 11 brokers.

Cipla Ltd.

29 Jul 2024

1508.65

1.08%

Result Update:Cipla

Buy: Cipla Ltd.

Target

Axis Direct

We have BUY on the stock.

Cipla Ltd. is trading below its 150 day SMA of 1523.2

Cipla Ltd.

28 Jul 2024

1508.65

1.08%

CIPLA LTD.

Accumulate: Cipla Ltd.

Target

Prabhudas Lilladhar

Cipla Ltd. is trading below its 150 day SMA of 1523.2

Cipla Ltd.

26 Jul 2024

1508.65

1.08%

The US and emerging markets drive earnings

Buy: Cipla Ltd.

Target

Motilal Oswal

Cipla delivered in-line 1QFY25 performance. It continued to track well in the US generics segment, with sales scaling an all-time quarterly high of USD250m.

Cipla Ltd. is trading below its 150 day SMA of 1523.2

Cipla Ltd.

26 Jun 2024

1508.65

1.08%

Classification of Goa inspection remains key

Buy: Cipla Ltd.

Target

Motilal Oswal

Considering a healthy pipeline of niche products and superior execution in the
branded generics segment, we value Cipla on SOTP basis (24x 12M forward
earnings and NPV of INR30 for g-Revlimid) to arrive at our TP of INR1,700. We
maintain BUY rating on the stock.